A phase II trial of neoadjuvant dasatinib (Neo-D) in muscle-invasive urothelial carcinoma of the bladder (miUCB): Hoosier Oncology Group GU07-122 trial.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Noah M. Hahn, Siamak Daneshmand, Edwin M. Posadas, Michael O. Koch, Richard Bihrle, Richard Foster, Timothy A. Masterson, Liang Cheng, Ziyue Liu, Timothy Breen, Mark T. Fleming, Ray Lance, Christopher W. Ryan, Christopher L. Corless, Matt D. Galsky, Ajjai Shivaram Alva, Carmen Mitchell, Steven S. Shen, Seth P. Lerner, Guru Sonpavde
Institutions: Indiana University Health, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, USC Norris Comprehensive Cancer Center, Cedars-Sinai Medical Center, Indiana University, Hoosier Cancer Research Network (United States), Virginia Oncology Associates, Eastern Virginia Medical School, OHSU Knight Cancer Institute, Oregon Health & Science University, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, University of Michigan, Baylor College of Medicine, Houston Methodist, Michael E. DeBakey VA Medical Center
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3011148724